Track market-moving stories before they get noisy

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 12.25; value investors should take notice.

For fiscal 2026, one analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.17 to $2.70 per share. AMN boasts an average earnings surprise of +53.3%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN should be on investors' short list.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Momentum investors should take note of this Business Services stock. AMN has a Momentum Style Score of A, and shares are up 2.4% over the past four weeks.

One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.17 to $2.70 per share. AMN boasts an average earnings surprise of +53.3%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, AMN should be on investors' short list.

Key Takeaways AMN Healthcare is poised for growth with its broad services, MSP momentum and demand from labor disruptions.AI tools in WorkWise and AMN Passport are boosting recruiting, engagement and workforce planning.Soft staffing markets, client concentration and regulatory challenges could pressure AMN's growth. AMN Healthcare Services, Inc. (AMN - Free Report) is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), rising labor disruption demand and investments in technology and AI-driven platforms. However, industry shifts, pricing pressure and healthcare cost-consciousness are major downsides.

Shares of this Zacks Rank #3 (Hold) company have jumped 126.9% in the year-to-date period against the industry's 14.6% decline. However, the S&P 500 Index has risen 10.3% in the said timeframe.

This renowned player in the healthcare total talent services space has a market capitalization of $1.35 billion. The company projects 98.5% of earnings growth for 2026 and expects to witness continued improvements in its business. AMN Healthcare surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average earnings surprise of 53.25%.

Image Source: Zacks Investment Research

Factors Favoring AMN StockHealthcare Workforce Solutions Strengthening Client Relationships: AMN Healthcare is benefiting from a shift in healthcare providers' workforce priorities. During the first-quarter 2026 earnings call, management noted that hospitals are no longer primarily focused on reducing contract labor usage. They are seeking long-term workforce optimization through predictive analytics, technology-enabled staffing and total talent management. The company strengthened its MSP business by adding a new Locum MSP client, and renewing and expanding its largest Locums contract. These developments, combined with deeper client relationships built during recent labor disruption events, position AMN to capture additional market share as healthcare organizations increasingly prefer strategic workforce partners over traditional staffing vendors.

AI and Technology Investments Driving Operational Efficiency: AMN continues to leverage artificial intelligence and digital tools to improve recruiting efficiency, clinician engagement and workforce management. The company introduced new AI-powered capabilities within its WorkWise platform, including automated candidate scoring, enhanced job search functionality and AI-assisted job description creation. Its AI recruiter helped deploy more than 10,000 clinicians during the quarter, while the AMN Passport mobile app recorded more than 30% growth in users and over 50% growth in monthly active users.

The company recently partnered with Brightfield to enhance its workforce intelligence capabilities. Brightfield's Talent Data Exchange (TDX) complements AMN's proprietary workforce insights, improving market transparency and labor planning. The partnership also enhances AMN's WorkWise ecosystem with stronger decision-support capabilities.

These technology investments are improving hiring speed, strengthening clinician engagement and enhancing workforce planning capabilities, supporting management's long-term goal of expanding revenue while improving operating leverage.

Improving Core Business Momentum and Financial Strength: Beyond the temporary boost from labor disruption events, AMN Healthcare's underlying businesses showed encouraging signs of recovery. Excluding labor disruption assignments, Nurse and Allied Solutions returned to year-over-year traveler volume growth for the first time since 2022, while international staffing posted its first year-over-year revenue increase since late 2023. Leadership search also returned to growth, reflecting improving demand across multiple service lines. With improving demand trends, disciplined capital management and management targeting sustainable revenue growth alongside faster adjusted EBITDA expansion, the company appears well positioned for long-term growth.

Downsides of AMN StockSoftness in Key Staffing Markets: Although AMN's Nurse and Allied business is showing signs of recovery, some of its core staffing markets remain under pressure. During first-quarter 2026, management noted that physician staffing demand remains soft, with many Locums clients focusing on centralized program management and hiring permanent physicians. Demand has also shifted toward the more competitive third-party channel, where fill rates are lower and pricing pressure is higher. At the same time, healthcare systems are investing in internal recruiting capabilities, workforce analytics and AI-powered staffing tools, which could reduce reliance on external staffing providers over time.

Client Concentration and Industry Consolidation Risks: Consolidation among healthcare providers continues to strengthen customers' bargaining power, allowing them to negotiate lower staffing rates and centralize workforce management. Mergers may also result in the loss of contracts if the combined organizations choose existing vendors. AMN Healthcare derives approximately 22% of its consolidated revenues from Kaiser Foundation Hospitals, making the company dependent on a single large customer. As healthcare organizations use vendor management systems and group purchasing organizations, pricing pressure and customer concentration could weigh on future revenue growth and margins.

Regulatory and Competitive Challenges: AMN operates in a highly regulated and competitive healthcare staffing industry. Changes in Medicare and Medicaid reimbursement, workforce regulations, immigration policies and evolving rules surrounding AI, cybersecurity and data privacy could increase compliance costs and influence customer hiring decisions. The company also faces competition from large national staffing firms, specialized healthcare recruiters and technology-driven workforce providers. As hospitals continue expanding in-house staffing programs and adopting AI-enabled workforce management solutions, AMN Healthcare must invest in technology and service innovation to protect its competitive position.

Estimate TrendAMN Healthcare has been witnessing a positive estimate revision trend for 2026. Over the past 60 days, the Zacks Consensus Estimate for its earnings per share has improved 40% to $2.70.

The Zacks Consensus Estimate for second-quarter 2026 revenues and earnings per share is pegged at $626 million and 22 cents, respectively, suggesting 4.9% and 26.7% declines from the year-ago reported numbers.

Key PicksSome better-ranked stocks from the broader medical space are West Pharmaceutical (WST - Free Report) , Intuitive Surgical (ISRG - Free Report) and Pacific Biosciences of California (PACB - Free Report) .

West Pharmaceutical, carrying a Zacks Rank #2 (Buy) at present, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

West Pharmaceutical has an estimated long-term earnings growth rate of 13.9%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 19.4%.

Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 core earnings per share of 85 cents, which missed the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.

Intuitive Surgical has a long-term estimated growth rate of 14.3%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.

Pacific Biosciences of California, carrying a Zacks Rank #2 at present, reported a first-quarter 2026 adjusted loss per share of 12 cents, which came narrower than the Zacks Consensus Estimate by 29.4%. Revenues of $37.2 million missed the Zacks Consensus Estimate by 9.3%.

Pacific Biosciences of California has an estimated earnings growth rate of 22.6% for 2026. PACB’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 29.8%.

Key Takeaways AMN partnered with Brightfield to strengthen healthcare workforce intelligence and market transparency.The alliance combines Brightfield's TDX with AMN analytics to improve planning and cost benchmarking.AMN's WorkWise ecosystem gains predictive insights to support proactive, data-driven workforce planning. AMN Healthcare (AMN - Free Report) recently announced a strategic partnership with Brightfield to strengthen its healthcare workforce intelligence capabilities. By combining Brightfield's third-party Talent Data Exchange (TDX) with AMN's proprietary workforce analytics, the collaboration is expected to provide healthcare organizations with deeper market transparency and more informed labor planning.

From an investor's perspective, the partnership is likely to reinforce AMN's technology-enabled workforce solutions portfolio and enhance the value proposition of its WorkWise ecosystem. The move also reflects the company's continued focus on AI-driven analytics and data-backed decision support, which could support stronger client engagement over the long term.

Likely Trend of AMN Stock Following the NewsShares of AMN have traded flat since the announcement yesterday. In the year-to-date period, shares of the company surged 101.2% against the industry’s 18.9% decline.  The S&P 500 increased 7.4% in the same time frame.

The Brightfield partnership is likely to strengthen AMN Healthcare's long-term growth strategy by enhancing the depth and credibility of its workforce intelligence offerings. The integration of independent market data with AMN's proprietary analytics is expected to improve workforce planning, labor cost benchmarking and predictive decision-making for healthcare clients, making its WorkWise ecosystem more differentiated.

As healthcare providers increasingly seek data-driven solutions to manage labor shortages and rising workforce costs, the enhanced platform is likely to support higher client retention, attract new customers and create additional cross-selling opportunities across AMN's broader total talent solutions portfolio.

AMN currently has a market capitalization of $1.21 billion.

Image Source: Zacks Investment Research

More on the AllianceThe collaboration combines Brightfield's TDX, which provides independent workforce market intelligence across both clinical and non-clinical roles, with AMN Healthcare's proprietary workforce analytics, clinical labor insights and real-time intelligence generated through its technology platforms and extensive client network. The integrated solution is expected to offer healthcare organizations a more comprehensive and validated view of workforce costs, labor rate competitiveness and broader market dynamics, enabling stakeholders across clinical, operational and financial functions to make more informed workforce decisions. The partnership also leverages the companies' AI-driven analytics capabilities to translate workforce data into actionable strategies aligned with clients' operational, financial and clinical objectives.

The alliance further strengthens AMN's broader WorkWise ecosystem strategy by enhancing its predictive workforce planning, analytics and decision-support capabilities. Through the expanded intelligence platform, healthcare organizations are expected to benchmark labor rates against independent market data, improve transparency in workforce cost discussions through third-party validation, optimize workforce mix and utilization and identify opportunities to better manage labor spending. By providing richer market intelligence and predictive insights, the collaboration is designed to help healthcare systems transition from reactive staffing decisions to more proactive, data-driven workforce planning in an increasingly complex healthcare labor market.

Favorable Industry Prospect for AMNPer a report by Grand View Research, the global healthcare staffing market size was valued at $82.2 billion in 2025 and is projected to grow from $87.9 billion in 2026 to $143.2 billion by 2033, at a CAGR of 7.2% from 2026 to 2033.

Growth is attributed to the increased knowledge of the benefits of temporary employment, job-related incentives and the availability of opportunities globally. 

A Recent Development by AMNRecently, AMN announced the acquisition of Jaide Health, an AI-enabled medical interpretation and translation platform, to expand language access for patients with Limited English Proficiency across the healthcare journey. The move enhances AMN’s Language Services capabilities by extending language assistance to important touchpoints before and after treatment while maintaining the critical role of qualified human interpreters for clinical, sensitive and complex discussions.

AMN’s Zacks Rank & Key PicksCurrently, AMN carries a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .

Globus Medical, currently carrying a Zacks Rank #2 (Buy), reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.

West Pharmaceutical, currently flaunting a Zacks Rank #1, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.

WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.

Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.

ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.

AMN Healthcare Logo. (PRNewsFoto/AMN Healthcare)

Brightfield Strategic collaboration expands AMN's healthcare workforce intelligence with broader and enriched market data to help healthcare organizations make smarter, faster, and more confident labor decisions

, /PRNewswire/ -- AMN Healthcare, the leader and innovator in healthcare total talent solutions, today announced it is expanding its workforce intelligence capabilities through a strategic partnership with Brightfield, a leader in measurable workforce intelligence, to deliver enhanced market intelligence and greater transparency to healthcare organizations. Brightfield's Talent Data Exchange, or TDX, adds third-party market data and validation to AMN's proprietary healthcare workforce insights. TDX provides an external view of workforce trends across both clinical and non-clinical roles, complementing AMN's deep healthcare workforce intelligence data that is powered by clinical labor insights, proprietary analytics, and real-time intelligence from its technology platforms and extensive client network.

The partnership delivers a more complete and validated view of workforce costs, rate competitiveness and market dynamics—combining proprietary data with expanded market context—to help health systems align stakeholders, strengthen decision-making, and drive more effective, data-backed workforce strategies.

"Healthcare organizations are under growing pressure to balance cost, quality, access and workforce stability in an increasingly complex labor market," said Kristy Willis, Chief Commercial Officer at AMN Healthcare. "By pairing Brightfield's independent data and analytics with AMN's deep healthcare workforce intelligence and analytics, we can give clients the most complete view of the market with third-party validation as a key differentiator — helping organizations build confidence, create alignment and make smarter workforce decisions backed by data they can trust."

The partnership leverages the strengths of both organization's extensive data and AI-driven analytics to translate meaningful insights into actionable workforce strategies aligned to each client's operational, financial and clinical goals. The collaboration is part of AMN's broader WorkWise ecosystem strategy, strengthening the company's ability to bring healthcare systems a more unified, data-driven approach to predictive workforce planning, analytics and decision support.

"At Brightfield, our focus is helping organizations bring greater intelligence, transparency and discipline to extended workforce decisions," said Sarah Koshiol, Chief Revenue Officer at Brightfield. "Together with AMN, we have an opportunity to bring that value to healthcare in a meaningful way — helping systems better understand the market, validate decisions and build more resilient workforce strategies for the future."

The partnership is designed to help healthcare organizations:

Benchmark labor rates against independent market intelligence Strengthen transparency in workforce cost and rate discussions validated through a third party Support more confident decision-making across clinical, operational and financial stakeholders Identify opportunities to optimize workforce mix, utilization and spend Move from reactive staffing decisions to more proactive workforce planning backed by even more market data About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025, our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.

About Brightfield
Brightfield is the leader in AI-driven workforce intelligence, helping Global 2000 enterprises optimize contingent and services procurement spend. Its proprietary platform, TDX, benchmarks millions of roles and rate points to deliver precise market intelligence, identify misclassifications, and unlock measurable savings. Brightfield empowers organizations to make smarter workforce decisions, reduce risk, and drive long-term value through data and AI.

Media Contact

Corporate Communications

AMN Healthcare

[email protected]

Investor Contact

Randle Reece

Vice President, Investor Relations & Strategy

AMN Healthcare

(866) 861-3229 | [email protected]

SOURCE AMN Healthcare Services, Inc.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 11.81; value investors should take notice.

Three analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.77 to $2.70 per share. AMN boasts an average earnings surprise of +53.3%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN should be on investors' short list.

Executive appointments reflect leadership momentum and coordinated investment in growth and people

, /PRNewswire/ -- AMN Healthcare, the leader and innovator in healthcare total talent solutions, today announced the appointments of Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, both effective June 15. In these roles, Willis and Novak will strengthen the company's executive leadership team as it advances its next phase of growth, innovation, and organizational alignment.

Kristy Willis, Chief Commercial Officer, AMN Healthcare

Holly Novak, Chief People Officer, AMN Healthcare Willis will lead a newly integrated commercial function bringing together sales, client accounts, marketing and supplier partnerships to create a growth engine for AMN's leading total talent solutions across both acute and nonacute settings powered by its AI-enabled WorkWise platform. Novak will lead the company's human resources function building on its strong culture to advance AMN Healthcare's people strategy for the future. Together, the appointments reflect a coordinated investment in the capabilities and partnerships that drive market growth and the people and culture that power long-term success.

"Kristy and Holly are exceptional leaders bringing strong expertise and skill to our leadership team in two areas that matter deeply to our future: client leadership and growth and our people," said Cary Grace, President and CEO of AMN Healthcare. "Kristy brings the commercial leadership and execution focus to help us sharpen our market strategy, differentiate our client value proposition and create stronger alignment across the client lifecycle. Holly is a transformative HR leader with the experience and expertise to continue building a place where our team members can thrive and do their best work."

As Chief Commercial Officer, Willis will lead an integrated commercial organization with a primary focus on client growth and market execution. She most recently served as President of PeopleReady, a $1.5 billion national workforce solutions business, part of the TrueBlue portfolio. Through her career, Willis has built successful commercial organizations that align sales strategy, customer experience, and execution at scale, while strengthening go-to-market discipline and driving performance in complex, highly regulated environments.

As Chief People Officer, Novak will lead AMN Healthcare's human resources function and help advance the company's people strategy during a time of growth and innovation. She brings more than 20 years of experience as a people leader and most recently served as Chief People Officer at Jack Henry, a financial technology company. Novak brings deep experience aligning people strategies to business goals and optimizing performance through talent management, succession planning, workforce analytics, and total rewards programs in complex, highly regulated organizations.

"As we continue evolving to meet the needs of our valued clients, clinicians, and team members, we are building an organization that is more connected, more agile, and well equipped to execute with speed and quality," added Grace.

About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025 our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.

Media Contact

Investor Contact

Corporate Communications

Randle Reece

AMN Healthcare

Vice President, Investor Relations & Strategy

[email protected]

AMN Healthcare

(866) 861-3229 | [email protected]

SOURCE AMN Healthcare Services, Inc.

Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million;
GAAP income of $1.59/share and adjusted EPS of $2.10

DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2026 financial results. Financial highlights are as follows:

Dollars in millions, except per share amounts.

 Q1 2026% Change Q1 2025Revenue$1,378.4100%Gross profit$368.886%Net income$62.2nmGAAP diluted EPS$1.59nmAdjusted diluted EPS*$2.10366%Adjusted EBITDA*$166.1159%    * See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table entitled “Non-GAAP Reconciliation Tables” for a reconciliation of non-GAAP items.

Business Highlights

First quarter revenue and earnings exceeded guidance with labor disruption, travel nurse, allied, and international nurse exceeding expectations.Travel nursing volume and revenue grew year over year for the first time since 2022.Allied, schools, international nurse, and search also delivered year-over-year revenue growth.Cash flow from operations of $562 million and our quarter-end cash balance of $561 million benefited from favorable timing of working capital related to recent labor disruption events.We ended the quarter with $750 million of debt, an undrawn revolving credit facility and a leverage ratio, calculated under the terms of our credit agreement, of 1.6x. “Our first quarter performance demonstrated strong execution across AMN, with results exceeding our expectations and guidance while navigating a dynamic market environment,” said Cary Grace, President and Chief Executive Officer of AMN Healthcare. “We delivered solid underlying growth in Nurse and Allied Solutions, saw momentum return in international staffing and search, and continued to advance our technology-enabled workforce solutions. The AMN team did an outstanding job supporting our clients and healthcare professionals, demonstrating the power of our enhanced technology platform and solutions to deliver at our highest level since the pandemic.”

First Quarter 2026 Results

Consolidated revenue for the quarter was $1.378 billion, a 100% increase from prior year and an 84% increase from the prior quarter. Net income was $62 million (4.5% of revenue), or $1.59 per diluted share, compared with net loss of $1 million (0.2% of revenue), or ($0.03) per diluted share in the first quarter of 2025. Adjusted diluted EPS in the first quarter was $2.10 compared with $0.45 in the same quarter a year ago.

Revenue for the Nurse and Allied Solutions segment was $1.127 billion, higher by 173% year over year and up 130% from the prior quarter. Travel nurse staffing revenue was higher by 12% year over year and 16% sequentially. Allied division revenue increased 3% year over year and sequentially. Labor disruption events contributed $722 million revenue in the quarter.

The Physician and Leadership Solutions segment reported revenue of $164 million, down 6% year over year and 3% lower sequentially. Locum tenens revenue was $131 million, down 7% year over year and 4% sequentially. Interim leadership revenue was down by 4% year over year and 5% lower sequentially. Our search businesses saw revenue increase by 4% both year over year and sequentially.

Technology and Workforce Solutions segment revenue was $87 million, a decrease of 15% year over year and 1% sequentially. Language services revenue was $69 million in the quarter, down 8% from the prior year and down 1% sequentially. Vendor management systems revenue was $16 million, 18% lower year over year and down 2% from the prior quarter.

Consolidated gross margin was 26.8%, 190 basis points lower year over year and up 70 basis points sequentially. Higher margins in the Nurse and Allied Solutions and Technology and Workforce Solutions segments drove the sequential improvement.

Consolidated SG&A expenses were $218 million, or 15.8% of revenue, compared with $148 million, or 21.4% of revenue, in the same quarter last year. SG&A was $152 million, or 20.3% of revenue, in the previous quarter. The year-over-year increase in SG&A costs was driven primarily by expenses related to the large labor disruption events in the quarter.

Income from operations was $117 million with an operating margin of 8.5%, compared with income of $13 million and 1.8%, respectively, in the same quarter last year. Adjusted EBITDA was $166 million, a year-over-year increase of 159%. Adjusted EBITDA margin was 12.1%, 280 basis points higher than the year-ago period.

At March 31, 2026, cash and cash equivalents totaled $561 million. Cash flow from operations was $562 million for the first quarter. The cash balance and cash flow benefited from favorable timing of working capital related to labor disruption events resulting in $367 million of client deposits at quarter end that will be settled in the coming months. Capital expenditures were $7 million. The Company ended the quarter with total debt outstanding of $750 million with nothing drawn on our revolving credit facility.

Second Quarter 2026 Outlook

MetricGuidance*Consolidated revenue$620 - $635 millionGross margin28.0% - 28.5%SG&A as percentage of revenue23.0% - 23.5%Operating margin(0.6%) - 0.1%Adjusted EBITDA margin6.7% - 7.2% *Note: Guidance percentage metrics are approximate.   For a reconciliation of adjusted EBITDA margin, see the table entitled “Reconciliation of Guidance Operating Margin to Guidance Adjusted EBITDA Margin” below.

Revenue in the second quarter of 2026 is expected to be 4-6% lower than the prior year, or down 3-5% excluding labor disruption revenue of approximately $10 million this quarter compared with $16 million in the second quarter of 2025. Nurse and Allied Solutions segment revenue is expected to be down 0-2% year over year. Physician and Leadership Solutions segment revenue is expected to be down 6-8% year over year. Technology and Workforce Solutions segment revenue is projected to be down 14-16% year over year, including a (4%) effect from the divestiture of Smart Square at the beginning of third quarter 2025.

Second quarter estimates for certain other financial items include depreciation of $15 million, depreciation in cost of revenue of $2.5 million, non-cash amortization expense of $18 million, share-based compensation expense of $7 million, integration and other expenses of $3 million, interest expense of $8 million, marginal adjusted tax rate of 28%, and 39.3 million diluted average shares outstanding.

Conference Call on May 7, 2026

AMN Healthcare Services, Inc. (NYSE: AMN) will host a conference call to discuss its first quarter 2026 financial results and second quarter 2026 outlook on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare’s website at http://ir.amnhealthcare.com. Interested parties may participate live via telephone by registering at this link. Registrants will receive confirmation and dial-in details. Following the conclusion of the call, a replay of the webcast will be available at the Company’s investor relations website.

About AMN Healthcare

AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, direct hire and retained search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools, and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry.
The Company’s common stock is listed on the New York Stock Exchange under the symbol “AMN.” For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication (“RSS”) as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://ir.amnhealthcare.com.

Non-GAAP Measures

This earnings release and the non-GAAP reconciliation tables included with the earnings release contain certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company’s condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, (3) adjusted net income, and (4) adjusted diluted EPS. The Company provides such non-GAAP financial measures because management believes that they are useful to both management and investors as a supplement, and not as a substitute, when evaluating the Company’s operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin, and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions, allocating resources and for determining certain incentive compensation objectives. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly titled non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company’s performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled “Non-GAAP Reconciliation Tables” under the caption entitled “Reconciliation of Non-GAAP Items” and the footnotes thereto or on the Company’s website at https://ir.amnhealthcare.com/financials/quarterly-results. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company’s website.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning future demand and supply for healthcare, contingent staffing and other services, client preferences, momentum in international staffing and search, our ability to advance our technology-enabled workforce solutions, settlement of client deposits, second quarter 2026 financial projections for consolidated and segment revenue, consolidated gross margin, operating margin, SG&A as a percent of revenue, adjusted EBITDA margin, labor disruption revenue, depreciation expense, depreciation in cost of revenue, share-based compensation expense, non-cash amortization expense, integration and other expenses, interest expense, adjusted tax rate, and number of diluted shares outstanding. The Company bases these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are also identified by words such as “believe,” "project," “anticipate,” “expect,” “intend,” “plan,” “will,” “may,” “estimates,” variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.

The targets and expectations noted in this release depend upon, among other factors, (i) the ability of our clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts, through predictive analytics, online recruiting, internal travel agencies and float pools, telemedicine or otherwise and successfully hire and retain permanent staff, (ii) the duration and extent to which hospitals and other healthcare entities adjust their utilization of temporary nurses and allied healthcare professionals, physicians, healthcare leaders and other healthcare professionals and workforce technology applications as a result of the labor market or economic conditions, (iii) the magnitude and duration of the effects of the post-COVID-19 pandemic environment or any future pandemic or health crisis on demand and supply trends, our business, its financial condition and our results of operations, (iv) our ability to effectively address client demand by attracting and placing nurses and other clinicians, (v) our ability to recruit and retain sufficient quality healthcare professionals at reasonable costs, (vi) our ability to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, or client needs and requirements, including implementing changes that will make our services more tech-enabled and integrated, (vii) our ability to manage the pricing impact that the labor market or consolidation of healthcare delivery organizations may have on our business, (viii) the effects of economic downturns, inflation or slow recoveries, which could result in less demand for our services, increased client initiatives designed to contain costs, including reevaluating their approach as it pertains to contingent labor and managed services programs, other solutions and providers, pricing pressures and negatively impact payments terms and collectability of accounts receivable, (ix) our ability to develop and evolve our current technology offerings and capabilities and implement new infrastructure and technology systems to optimize our operating results and manage our business effectively, (x) our ability and the expense to comply with extensive and complex federal and state laws and regulations related to the conduct of our operations, costs and payment for services and payment for referrals as well as laws regarding employment practices, (xi) our ability to consummate and effectively incorporate acquisitions into our business, (xii) the negative effects that intermediary organizations may have on our ability to secure new and profitable contracts, (xiii) the extent to which the Great Resignation or a future spike in the COVID-19 pandemic or other pandemic or health crisis may disrupt our operations due to the unavailability of our employees or healthcare professionals due to burnout, illness, risk of illness, quarantines, travel restrictions, mandatory vaccination requirements, or other factors that limit our existing or potential workforce and pool of candidates, (xiv) security breaches and cybersecurity incidents, including ransomware, that could compromise our information and systems, which could adversely affect our business operations and reputation and could subject us to substantial liabilities and (xv) the severity and duration of the impact the labor market, economic downturn or any future pandemic or health crisis has on the financial condition and cash flow of many hospitals and healthcare systems such that it impairs their ability to make payments to us, timely or otherwise, for services rendered.

For a discussion of additional risk factors and a more complete discussion of some of the cautionary statements noted above that could cause actual results to differ from those implied by the forward-looking statements contained in this press release, please refer to our most recent Annual Report on Form 10-K for the year ended December 31, 2025. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated and the Company is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

Contact:
Randle Reece
Vice President, Investor Relations & Strategy
866.861.3229

  AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(in thousands, except per share amounts)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025Revenue$1,378,361  $689,533  $748,225 Cost of revenue 1,009,525   491,413   553,098 Gross profit 368,836   198,120   195,127 Gross margin 26.8%  28.7%  26.1%Operating expenses:     Selling, general and administrative (SG&A) 218,425   147,731   152,113 SG&A as a % of revenue 15.8%  21.4%  20.3%      Depreciation and amortization (exclusive of depreciation included in cost of revenue) 33,240   37,882   34,854 Loss on sale of disposal group —   —   42 Total operating expenses 251,665   185,613   187,009 Income from operations 117,171   12,507   8,118 Operating margin (1) 8.5%  1.8%  1.1%      Interest expense, net, and other 6,712   12,324   12,280       Income (loss) before income taxes 110,459   183   (4,162)      Income tax expense 48,293   1,275   3,534 Net income (loss)$62,166  $(1,092) $(7,696)Net income (loss) as a % of revenue 4.5% (0.2)% (1.0)%      Other comprehensive income (loss):     Unrealized gains (losses) on available-for-sale securities, net, and other (185)  61   (286)Other comprehensive income (loss) (185)  61   (286)      Comprehensive income (loss)$61,981  $(1,031) $(7,982)      Net income (loss) per common share:     Basic$1.60  $(0.03) $(0.20)Diluted$1.59  $(0.03) $(0.20)Weighted average common shares outstanding:     Basic 38,902   38,312   38,733 Diluted 39,118   38,312   38,733        AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
(unaudited)
          March 31, 2026
 December 31, 2025
 March 31, 2025
Assets        Current assets:        Cash and cash equivalents$560,738  $33,972  $55,777 Accounts receivable, net 394,668   382,560   421,869 Accounts receivable, subcontractor 47,501   48,041   65,307 Prepaid and other current assets 133,613   80,803   84,404 Total current assets 1,136,520   545,376   627,357 Restricted cash, cash equivalents and investments 45,814   45,606   45,070 Fixed assets, net 126,029   136,361   177,996 Other assets 263,408   282,552   253,670 Deferred income taxes, net 11,212   44,877   31,637 Goodwill 755,809   755,809   897,456 Intangible assets, net 265,581   283,526   361,937 Total assets$2,604,373  $2,094,107  $2,395,123          Liabilities and stockholders’ equity        Current liabilities:        Accounts payable and accrued expenses$197,385  $161,968  $195,974 Accrued compensation and benefits 317,137   298,837   269,497 Other current liabilities 529,668   116,809   116,778 Total current liabilities 1,044,190   577,614   582,249 Revolving credit facility —   25,000   150,000 Notes payable, net 742,491   742,053   846,167 Other long-term liabilities 104,886   107,334   101,656 Total liabilities 1,891,567   1,452,001   1,680,072          Commitments and contingencies                 Stockholders’ equity: 712,806   642,106   715,051          Total liabilities and stockholders’ equity$2,604,373  $2,094,107  $2,395,123           AMN Healthcare Services, Inc.
Summary Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025      Net cash provided by operating activities$562,452  $92,671  $75,572 Net cash used in investing activities (7,504)  (26,046)  (8,053)Net cash used in financing activities (27,135)  (61,211)  (83,242)Net increase (decrease) in cash, cash equivalents and restricted cash 527,813   5,414   (15,723)Cash, cash equivalents and restricted cash at beginning of period 67,171   89,305   82,894 Cash, cash equivalents and restricted cash at end of period$594,984  $94,719  $67,171              AMN Healthcare Services, Inc.
Non-GAAP Reconciliation Tables
(dollars in thousands, except per share data)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025Reconciliation of Non-GAAP Items:           Net income (loss)$62,166  $(1,092) $(7,696)Income tax expense 48,293   1,275   3,534 Income (loss) before income taxes 110,459   183   (4,162)Interest expense, net, and other 6,712   12,324   12,280 Income from operations 117,171   12,507   8,118 Depreciation and amortization 33,240   37,882   34,854 Depreciation (included in cost of revenue) (2) 2,420   1,975   2,376 Loss on sale of disposal group —   —   42 Share-based compensation 9,892   9,381   5,762 Acquisition, integration, and other costs (3) 3,402   2,455   3,331 Adjusted EBITDA (4)$166,125  $64,200  $54,483       Adjusted EBITDA margin (5) 12.1%  9.3%  7.3%      Net income (loss)$62,166  $(1,092) $(7,696)Adjustments:     Amortization of intangible assets 17,945   19,427   18,551 Acquisition, integration, and other costs (3) 3,402   2,455   3,331 Loss on sale of disposal group —   —   42 Debt financing related costs —   —   1,156 Tax effect on above adjustments (5,550)  (5,689)  (6,001)Tax effect of COLI fair value changes (6) 2,065   703   (1,713)Tax deficiencies (benefits) related to equity awards and ESPP (7) 2,151   1,523   892 Adjusted net income (8)$82,179  $17,327  $8,562       GAAP diluted net income (loss) per share (EPS)$1.59  $(0.03) $(0.20)Adjustments 0.51   0.48   0.42 Adjusted diluted EPS (9) (10)$2.10  $0.45  $0.22              AMN Healthcare Services, Inc.
Supplemental Segment Financial and Operating Data
(dollars in thousands, except operating data)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025Revenue     Nurse and allied solutions$1,127,342  $413,261  $490,710 Physician and leadership solutions 163,924   174,065   169,552 Technology and workforce solutions 87,095   102,207   87,963  $1,378,361  $689,533  $748,225       Segment operating income (11)     Nurse and allied solutions$153,330  $32,238  $36,484 Physician and leadership solutions 10,818   14,462   12,918 Technology and workforce solutions 25,270   35,250   24,896   189,418   81,950   74,298 Unallocated corporate overhead (12) 23,293   17,750   19,815 Adjusted EBITDA (4)$166,125  $64,200  $54,483       Gross Margin     Nurse and allied solutions 25.1%  22.7%  21.6%Physician and leadership solutions 26.1%  27.3%  27.5%Technology and workforce solutions 50.0%  55.5%  48.1%            Operating Data:     Nurse and allied solutions     Average travelers on assignment (13) 9,227   8,981   8,722       Physician and leadership solutions     Days filled (14) 46,645   51,342   48,004 Revenue per day filled (15)$2,812  $2,743  $2,834         As of March 31, As of December 31, 2026 2025 2025Leverage ratio (16)1.6 3.1 3.3       AMN Healthcare Services, Inc.
Additional Supplemental Non-GAAP Disclosure
Reconciliation of Guidance Operating Margin to Guidance
Adjusted EBITDA Margin
(unaudited)
   Three Months Ended June 30, 2026 Low(17) High(17)    Operating margin(0.6)% 0.1%Depreciation and amortization (total)5.7% 5.5%EBITDA margin5.1% 5.6%Share-based compensation1.1% 1.1%Integration and other costs0.5% 0.5%Adjusted EBITDA margin6.7% 7.2% (1)Operating margin represents income from operations divided by revenue.(2)A portion of depreciation expense for AMN Language Services is included in cost of revenue. We exclude the impact of depreciation included in cost of revenue from the calculation of adjusted EBITDA.(3)Acquisition, integration, and other costs include acquisition and integration costs, net changes in the fair value of contingent consideration liabilities for recently acquired companies, certain legal expenses, restructuring expenses and other costs associated with exit or disposal activities, and certain nonrecurring expenses, which we exclude from the calculation of adjusted EBITDA, adjusted net income, and adjusted diluted EPS because we believe that these expenses are not indicative of the Company’s operating performance. For the three months ended March 31, 2026, acquisition and integration costs were approximately $0.9 million, certain legal expenses were approximately $1.0 million, restructuring expenses and other costs associated with exit or disposal activities were approximately $0.6 million, and other nonrecurring expenses were approximately $0.9 million. For the three months ended March 31, 2025, acquisition and integration costs were approximately $0.3 million, expenses related to the closures of certain office leases were approximately $0.2 million, certain legal expenses were approximately $1.1 million, restructuring expenses and other costs associated with exit or disposal activities were approximately $0.4 million, and other nonrecurring expenses were approximately $0.4 million. For the three months ended December 31, 2025, acquisition and integration costs were approximately $0.5 million, certain legal expenses were approximately $0.8 million, expenses related to the closures of certain office leases were approximately $0.2 million, restructuring expenses and other costs associated with exit or disposal activities were approximately $0.8 million, and other expenses were approximately $1.0 million.(4)Adjusted EBITDA represents net income (loss) plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, depreciation (included in cost of revenue), loss on sale of disposal group, share-based compensation, acquisition, integration, and other costs, restructuring expenses, and certain legal expenses. Management believes that adjusted EBITDA provides an effective measure of the Company’s results, as it excludes certain items that management believes are not indicative of the Company’s operating performance. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income (loss) as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income (loss), and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income (loss).(5)Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.(6)The Company records net tax expense (benefit) related to the income tax treatment of the fair value changes in the cash surrender value of its company owned life insurance (“COLI”). Since this change in fair value is unrelated to the Company’s operating performance, we excluded the impact on adjusted net income and adjusted diluted EPS.(7)The consolidated effective tax rate is affected by the recording of tax benefits and tax deficiencies related to equity awards vested during the period and tax benefits recognized for disqualifying dispositions related to our employee stock purchase plan (“ESPP”). The magnitude of the impact of tax benefits and tax deficiencies generated in the future related to equity awards and ESPP is dependent upon the Company’s future grants of share-based compensation, the Company’s future stock price on the date equity awards vest in relation to the fair value of the awards on the grant date, the Company’s future stock price on either the ESPP’s offering date or purchase date, whichever is lower, and the length of time the shares issued under the ESPP are held by employees. Since these tax benefits and tax deficiencies related to equity awards and ESPP are largely unrelated to our income (loss) before income taxes and are unrepresentative of our normal effective tax rate, we excluded their impact in the calculation of adjusted net income and adjusted diluted EPS.(8)Adjusted net income represents GAAP net income (loss) excluding the impact of the (A) amortization of intangible assets, (B) acquisition, integration, and other costs, (C) loss on sale of disposal group, (D) deferred financing related costs, (E) tax effect, if any, of the foregoing adjustments, (F) net tax expense (benefit) related to the income tax treatment of fair value changes in the cash surrender value of its COLI and (G) tax deficiencies and tax benefits related to equity awards vested and ESPP. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company’s operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded in the calculation of adjusted net income). Although management believes the items in the calculation of adjusted net income are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income (loss), and management therefore utilizes adjusted net income as an operating performance measure in conjunction with GAAP measures such as GAAP net income (loss).(9)Adjusted diluted EPS represents adjusted net income divided by diluted weighted average common shares outstanding. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company’s operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded in the calculation of adjusted net income). Although management believes the items in the calculation of adjusted net income are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income (loss), and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.(10)As GAAP net loss is reported for the three months ended March 31, 2025 and December 31, 2025, basic weighted average common shares outstanding was used to calculate GAAP diluted EPS for those periods because the dilutive potential common shares have an anti-dilutive effect (i.e., result in a lower loss per share). As adjusted net income is reported for the three months ended March 31, 2025 and December 31, 2025, diluted weighted average common shares outstanding (including dilutive potential common shares) of 38,414 and 38,817, respectively, were used to calculate adjusted diluted EPS.(11)Segment operating income represents net income (loss) plus interest expense (net of interest income) and other, income tax expense (benefit), depreciation and amortization, depreciation (included in cost of revenue), unallocated corporate overhead, acquisition, integration, and other costs, legal settlement accrual changes, share-based compensation, and loss on sale of disposal group.(12)Unallocated corporate overhead (as presented in the tables above) consists of unallocated corporate overhead (as reflected in our quarterly and annual financial statements filed with the SEC) less acquisition, integration, and other costs and legal settlement accrual changes.(13)Average travelers on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.(14)Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.(15)Revenue per day filled represents revenue of the Company’s locum tenens business divided by days filled for the period presented.(16)Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company’s credit agreement) at the end of the subject period to the consolidated adjusted EBITDA (as calculated per the Company’s credit agreement) for the twelve-month period ended at the end of the subject period.(17)Guidance percentage metrics are approximate.
  

AMN Healthcare Services (AMN - Free Report) came out with quarterly earnings of $2.1 per share, beating the Zacks Consensus Estimate of $1.6 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +30.98%. A quarter ago, it was expected that this health care staffing company would post earnings of $0.22 per share when it actually produced earnings of $0.22, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

AMN Healthcare, which belongs to the Zacks Business - Services industry, posted revenues of $1.38 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 11.90%. This compares to year-ago revenues of $689.53 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

AMN Healthcare shares have added about 33.1% since the beginning of the year versus the S&P 500's gain of 7.6%.

What's Next for AMN Healthcare?While AMN Healthcare has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for AMN Healthcare was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.10 on $627.69 million in revenues for the coming quarter and $1.93 on $3.14 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Business - Services is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Priority Technology (PRTH - Free Report) , another stock in the broader Zacks Business Services sector, has yet to report results for the quarter ended March 2026. The results are expected to be released on May 11.

This company is expected to post quarterly earnings of $0.22 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Priority Technology's revenues are expected to be $240.35 million, up 7% from the year-ago quarter.

For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Is AMN Healthcare Services (AMN - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Business Services sector should help us answer this question.

AMN Healthcare Services is a member of our Business Services group, which includes 234 different companies and currently sits at #10 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. AMN Healthcare Services is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for AMN's full-year earnings has moved 164.8% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, AMN has moved about 42.5% on a year-to-date basis. In comparison, Business Services companies have returned an average of -10.1%. This means that AMN Healthcare Services is outperforming the sector as a whole this year.

HireQuest, Inc. (HQI - Free Report) is another Business Services stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 16.3%.

Over the past three months, HireQuest, Inc.'s consensus EPS estimate for the current year has increased 6%. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, AMN Healthcare Services belongs to the Business - Services industry, a group that includes 20 individual companies and currently sits at #68 in the Zacks Industry Rank. This group has lost an average of 13.2% so far this year, so AMN is performing better in this area.

On the other hand, HireQuest, Inc. belongs to the Staffing Firms industry. This 13-stock industry is currently ranked #155. The industry has moved +7.1% year to date.

Going forward, investors interested in Business Services stocks should continue to pay close attention to AMN Healthcare Services and HireQuest, Inc. as they could maintain their solid performance.

MarketBeat Instant News Alerts Trending News All MarketBeat Instant News Alerts Sort By

Time Frame

Alert Type

Keywords

Page 1 of 323

Get 30 Days of MarketBeat All Access for Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.

Start Your 30-Day Trial

Sign in to your free account to enjoy these benefits

In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer.

DALLAS, May 13, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026.

Palmer is a seasoned healthcare executive with more than 25 years of leadership experience across healthcare services, benefits, and insurance industries. He has a strong track record of leading large-scale operations, driving strategic growth initiatives, and executing complex mergers, acquisitions, and divestitures.

“Eric’s extensive leadership experience, understanding of the healthcare ecosystem and alignment to our mission make him a valuable addition to our Board,” said Cary Grace, President and CEO of AMN Healthcare. “His proven ability to scale complex organizations and navigate dynamic market environments will strengthen our governance and support AMN’s long-term growth strategy.”

Palmer most recently served as Chief Executive Officer of Evernorth Health Services, where he led the organization’s growth to more than $200 billion in revenue, establishing it as a market leader in specialty pharmacy, pharmacy benefits, and care management services. Prior to that, he served as Chief Financial Officer of Cigna, where he played a central role in driving the transformational acquisition of Express Scripts, successfully combining two Fortune 100 companies.

“AMN’s commitment to empowering healthcare organizations and professionals deeply aligns with the work I’ve done throughout my career,” said Palmer. “I am honored to join the Board and am excited to support AMN’s mission to empower high-quality care through innovative workforce solutions.”

Palmer currently serves on the board of directors of LifeStance Health and is on the board of trustees of Kingswood-Oxford School and Connecticut Children’s Medical Center.

For more information about AMN Healthcare’s leadership team, please visit www.amnhealthcare.com.

About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025 our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.

AMN Healthcare Services, Inc. (AMN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Investors in AMN Healthcare Services (AMN - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 18, 2026 $05.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?Clearly, options traders are pricing in a big move for AMN Healthcare Services share, but what is the fundamental picture for the company? Currently, AMN Healthcare Services is a Zacks Rank #3 (Hold) in the Business - Services Industry that ranks in the Top 39% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased his estimate for the current quarter, while none have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter to move from 10 cents per share to 188 cents per share in the same time period.

Given the way analysts feel about AMN Healthcare Services right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Key Takeaways AMN shares are up 86.1% YTD, even as the industry declined 17.4% over the same stretch.AMN posted $722M labor disruption revenues in Q1 2026, handling five events and deploying thousands.AMN faces tech and language pricing pressure: segment revenues fell 15% YoY and language services lost 8%. AMN Healthcare Services, Inc. (AMN - Free Report) is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), rising labor disruption demand and investments in technology and AI-driven platforms. However, industry shifts, pricing pressure and healthcare cost-consciousness are major downsides.

Shares of this Zacks Rank #3 (Hold) company have jumped 86.1% in the year-to-date period against the industry's 17.4% decline. However, the S&P 500 Index has risen 11.1% in the said timeframe.

This renowned player in the healthcare total talent services space has a market capitalization of $1.12 billion. The company projects 98.5% of earnings growth for 2026 and expects to witness continued improvements in its business. AMN Healthcare surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average earnings surprise of 53.25%.

Image Source: Zacks Investment Research

Factors Favoring AMN StockHealthcare MSP: AMN Healthcare continues to expand its Managed Services Program (MSP) presence as healthcare organizations seek more efficient workforce management solutions. During first-quarter 2026, management noted that many clients have shifted their focus from reducing contract labor usage to optimizing total workforce costs through predictive analytics, workforce planning and technology-enabled staffing strategies.

First-quarter 2026 results highlighted the model’s scalability during multiple labor disruption events, and management added a new locum MSP client and expanded its largest locums contract. As healthcare providers seek strategic workforce partners rather than transactional staffing vendors, AMN’s MSP capabilities position it to deepen client relationships, improve retention and capture additional market share over time.

AI and Workforce Technology Investments Enhancing Scalability: AMN Healthcare continues to invest in AI, automation and analytics to improve hiring efficiency and clinician engagement. In first-quarter 2026, travel nurse revenues rose 13% year over year, allied revenues increased 3%, international staffing returned to growth and leadership search expanded. AMN also demonstrated rapid scalability during major labor disruptions. Through its WorkWise workforce technology platform, the company rolled out AI-driven candidate scoring, search and job-description tools. Its AI recruiter deployed over 10,000 clinicians. AMN Passport users grew over 30%, monthly active users rose over 50% and language services delivered sequential gross margin improvement.

Labor Disruption Capabilities Creating a Competitive Advantage: AMN’s ability to support multiple large labor disruption events emerged as a major strength in the first quarter of 2026. The company generated $722 million in labor disruption revenues while successfully managing five labor disruption events. Management highlighted that investments in event management systems, AI-enabled recruiting tools and scalable operating processes allowed AMN to rapidly deploy thousands of clinicians.

These capabilities strengthen relationships with strategic healthcare clients and reinforce AMN’s position as a trusted workforce partner during critical situations. The company believes this level of execution would not have been possible a few years ago, underscoring the value of its technology investments and broad clinician network.

Downsides of AMN StockHealthcare Cost-Consciousness Limiting Growth: Hospital systems remain heavily focused on workforce cost management despite improving patient utilization trends. Clients continue to prioritize efficiency, predictive workforce planning and labor optimization rather than expanding staffing budgets.

Bill-rate growth remains limited, with increases largely occurring only when difficult-to-fill positions create urgent staffing needs. AMN noted that healthcare providers are increasingly evaluating technology, analytics and workforce planning tools to improve internal staffing efficiency. Continued emphasis on cost containment could restrict demand growth, slow pricing recovery and create a challenging environment for staffing providers across several service lines.

Continued Pricing Pressure in Technology and Language Services: AMN’s Technology and Workforce Solutions segment remains under pressure from competitive pricing dynamics. Segment revenues declined 15% year over year, while language services revenues fell 8%. Management indicated that pricing pressure persists across the language services market, although conditions have become more stable than in prior periods.

The company has implemented service model changes, including greater offshore utilization and operational efficiencies, to protect profitability. However, management expects competition to remain intense and acknowledged that pricing headwinds could continue as contracts renew, creating ongoing pressure on revenue growth and margins.

Healthcare Industry Regulations: AMN Healthcare operates in a highly regulated industry subject to federal and state laws governing reimbursement, workforce practices, privacy, cybersecurity and AI usage. Although clients pay AMN directly, changes in Medicare and Medicaid reimbursement can indirectly affect demand and pricing, while client non-compliance may reduce business activity. The company also serves government clients and must meet specific regulatory requirements. Increasing regulation could raise compliance costs and operational risks. In addition, changes in immigration policies remain an important variable for international nurse staffing, which returned to year-over-year growth in first-quarter 2026 after a period of weakness.

Estimate TrendAMN Healthcare has been witnessing a positive estimate revision trend for 2026. Over the past 60 days, the Zacks Consensus Estimate for its earnings per share has improved 37.7% to $2.70.

The Zacks Consensus Estimate for second-quarter 2026 revenues and earnings per share is pegged at $625.7 million and 22 cents, respectively, suggesting 4.9% and 26.7% declines from the year-ago reported numbers.

Key PicksSome better-ranked stocks in the broader medical space are West Pharmaceutical Services (WST - Free Report) , Align Technology (ALGN - Free Report) and Biodesix (BDSX - Free Report) . While West Pharmaceutical Services and Align Technology sport a Zacks Rank #1 (Strong Buy) each at present, Biodesix carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

West Pharmaceutical Services has an estimated long-term growth rate of 13.9%. WST's earnings surpassed estimates in each of the trailing four quarters, with the average being 19.4%.

West Pharmaceutical Services’ stock has gained 14.9% against the industry's 9.3% decline in the year-to-date period.

Align Technology's earnings surpassed estimates in three of the trailing four quarters and missed one, with the average surprise being 7.8%.

ALGN's shares have risen 8.7% in the year-to-date period against the industry’s 9.3% decline.

Biodesix's earnings surpassed estimates in three of the trailing four quarters and missed one, with the average surprise being 25.6%.

BDSX's shares have rallied 124.6% in the year-to-date period against the industry’s 9.7% decline.

AMN Healthcare Services, Inc. (AMN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript